Today, the International Renewable Energy Agency (IRENA) signed a cooperation agreement with the Africa 50 Fund, an investor and asset manager in infrastructure projects across the African continent, to accelerate the deployment of renewable energy in Africa.
Khelo India women's kho-kho season starts with the zonal in northern India. Punjab will host the age-group events and those will be followed by the senior national phase 1 league in Uttar Pradesh
The agency's latest report underscores how India's heavy reliance on monsoon rainfall, coupled with rapid economic growth and exacerbated by climate change, could severely impact various sectors, including agriculture, industry, and infrastructure.
New Delhi [India], June 25: In this modern era of the digital age, experiential marketing continues to be one of the most intriguing buzzwords in the marketing industry. Many startups are entering this arena, and it's clear that the industry is experiencing significant growth. However, one r
Bangalore (Karnataka) [India], June 25: Ashoka Innovators for the Public (India), which supports the country's largest network of social entrepreneurs and young changemakers, has started accepting applications from India for the 2024 edition of their Young Changemakers cohort. The applicatio
Videos posted on Kuaishou, a Chinese short-video platform, depicted a cylindrical piece of debris descending over a rural village, crashing near a hill with yellow smoke billowing from one end.
Amidst the alleged irregularities in the NEET examination 2024 conducted by the National Testing Agency (NTA), Congress' student organisation, West Bengal State Chhatra Parishad, demonstrated against Union Education Minister Dharmendra Pradhan and demanded his resignation over the issue.
Union Minister Chirag Paswan said on Monday that the government has "nothing to hide" regarding the ongoing row over alleged irregularities in the conduct of NEET-UG exam by the National Testing Agency (NTA).
According to a press release, this facility, designed to produce multiple drug substances, will now commence the production of biosimilar Bevacizumab, enhancing the company's capacity to meet the growing demand for biologics across European markets.